Organon Q2 Adj. EPS $1.31 Beats $0.97 Estimate, Sales $1.61B Beat $1.56B Estimate
Portfolio Pulse from Benzinga Newsdesk
Organon (NYSE:OGN) reported Q2 earnings of $1.31 per share, beating the analyst consensus estimate of $0.97 by 35.05%. This is a 4.8% increase from the same period last year. The company also reported quarterly sales of $1.61 billion, beating the analyst consensus estimate of $1.56 billion by 3.01%. This is a 1.45% increase from the same period last year.
August 08, 2023 | 11:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Organon's Q2 earnings and sales exceeded analyst estimates, indicating a positive financial performance.
Organon's Q2 earnings and sales have exceeded analyst estimates, which is typically a positive signal for the company's financial performance and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100